Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OMALIZUMAB Cause Haemarthrosis? 14 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Haemarthrosis have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.0% of all adverse event reports for OMALIZUMAB.

14
Reports of Haemarthrosis with OMALIZUMAB
0.0%
of all OMALIZUMAB reports
1
Deaths
12
Hospitalizations

How Dangerous Is Haemarthrosis From OMALIZUMAB?

Of the 14 reports, 1 (7.1%) resulted in death, 12 (85.7%) required hospitalization, and 1 (7.1%) were considered life-threatening.

Is Haemarthrosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does OMALIZUMAB Cause?

No adverse event (9,736) Asthma (9,354) Urticaria (9,231) Off label use (9,199) Dyspnoea (8,323) Drug ineffective (6,747) Cough (5,926) Pruritus (5,224) Fatigue (5,053) Malaise (4,820)

What Other Drugs Cause Haemarthrosis?

ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (3,360) EMICIZUMAB-KXWH (487) RIVAROXABAN (429) COAGULATION FACTOR IX RECOMBINANT HUMAN (318) DAMOCTOCOG ALFA PEGOL (299) --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (220) ASPIRIN (208) EFTRENONACOG ALFA (196) COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL (190) APIXABAN (169)

Which OMALIZUMAB Alternatives Have Lower Haemarthrosis Risk?

OMALIZUMAB vs OMAVELOXOLONE OMALIZUMAB vs OMBITASVIR OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS

Related Pages

OMALIZUMAB Full Profile All Haemarthrosis Reports All Drugs Causing Haemarthrosis OMALIZUMAB Demographics